Sign in

CIK 0001213037

  • Non-accelerated filer
  • Smaller reporting company

Cardiff Oncology, Inc.

Sign in to watch
Ticker
CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272004382
Phone
+1 858-952-7570
Business address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
Former names
Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
  1. 4 Open-market buy Director bought 15,000 shares at $1.64 ($24,525)
  2. 4 Open-market buy Director bought 10,000 shares at an average $1.72 ($17,168)
  3. 4 Open-market buy Director bought 150,000 shares at $1.71 ($256,500)
  4. 4 Open-market buy Chief Financial Officer bought 30,000 shares at $1.56 ($46,710)
  5. 4 Option exercise Director acquired 28,858 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market buy Director bought 30,000 shares at $6.75 ($202,500)
  20. 4 Open-market buy Chief Financial Officer bought 30,000 shares at an average $6.47 ($194,000)

Page 4 of 15 · 300 filings